PT  - JOURNAL ARTICLE
AU  - Helwick, Caroline
ED  - Llovet, Josep M.
TI  - Sorafenib Improves Survival in Hepatocellular Carcinoma: Results of a Phase 3 Randomized, Placebo-Controlled Trial
DP  - 2007 Sep 01
TA  - MD Conference Express
PG  - 11--11
VI  - 7
IP  - 3
4099  - http://mdc.sagepub.com/content/7/3/11.short
4100  - http://mdc.sagepub.com/content/7/3/11.full
AB  - The Sorafenib HCC Assessment Randomized Protocol [SHARP] trial demonstrated that treatment with sorafenib prolonged overall survival by 44% and prolonged time to progression by 73% for patients with advanced hepatocellular carcinoma.